Table 2.
Case | Age (years) | Sex | IM* | PPM* | Location† |
1 | 9 | F | 1 | 0 | A |
2 | 9 | F | 2 | 1 | A, B3 |
3 | 12 | F | 0 | 1 | B3 |
4 | 16 | F | 1 | 0 | A |
5 | 15 | M | 0 | 1 | B2 |
6 | 17 | M | 1 | 0 | C |
7 | 15 | M | 0 | 1 | C |
8 | 15 | M | 3 | 0 | C |
9 | 15 | M | 0 | 3, 2 | B3, B2 |
10 | 15 | F | 0 | 2 | B2 |
11 | 15 | F | 0 | 1 | B2 |
12 | 12 | F | 0 | 1 | B2 |
13 | 12 | M | 1 | 0 | A |
14 | 10 | F | 0 | 1 | B2 |
15 | 10 | M | 0 | 3 | C, B3 |
16 | 14 | M | 0 | 1 | B2 |
*Scored on a visual analogue scale of 0–5; †when atrophy is present in more than one biopsy, the first figure relates to IM and the second to PPM. For example, patient 2 has IM (score 2) in the antrum and PPM (score 1) at location B3.
IM, intestinal metaplasia; PPM, pseudopyloric metaplasia.